Hortapharm B.V.

Last updated
HortaPharm B.V.
IndustryHorticulture
Founder David Paul Watson
Headquarters,
ProductsCannabis seeds and clones

HortaPharm B.V. is a cannabis research business headquartered in the Netherlands. [1]

Contents

History

The business was founded by American David Watson also known as Sam Selezny or 'SkunkMan Sam' in the early 1990s, with seeds he created for his company, Sacred Seeds in California. David, Pate, and Robert C. Clarke were employed by the company. [2] From September 1994 until September 1997 HortaPharm had a permit from the Dutch Ministry of Health for scientific research of cannabis; this permit was rescinded due to compliance issues. In 1998, HortaPharm B.V. began work with GW Pharmaceuticals to develop cannabis strains for the manufacture of pharmaceuticals. [3]

Research

HortaPharm B.V. has used selective breeding and production for research of cannabis strains, with a focus on the isolation of tetrahydrocannabinol or cannabidiol. [4] GW Pharmaceuticals has exclusive rights to all genetics produced by HortaPharm B.V with the goal of producing one-off sterile female plants to control supply. [5] Lab Supervisor, David Pate, gave a lecture at the National Academy of Sciences in Washington, D. C. on February 24, 1998, as part of the Institute of Medicine study to evaluate the therapeutic value of marijuana and its chemical components. [6]

Patents

In March of 2000, HortaPharm B.V. filed a patent for a vaporizer with enhanced isolation chambers for ascending-steam extraction, with the invention attributed to David Pate. [7] GW Pharmecuticals have filed multiple patents based on their work with HortaPham B.V.

Related Research Articles

<span class="mw-page-title-main">Vaporizer (inhalation device)</span> Device to vaporize substances for inhalation

A vaporizer or vaporiser, colloquially known as a vape, is a device used to vaporize substances for inhalation. Plant substances can be used, commonly cannabis, tobacco, or other herbs or blends of essential oil. However, they are most commonly filled with a combination propylene glycol, glycerin, and drugs such as nicotine or tetrahydrocannabinol as a liquid solution.

<span class="mw-page-title-main">Tetrahydrocannabivarin</span> Homologue of tetrahydrocannabinol

Tetrahydrocannabivarin is a homologue of tetrahydrocannabinol (THC) having a propyl (3-carbon) side chain instead of pentyl (5-carbon), making it non-psychoactive in lower doses. It has been shown to exhibit neuroprotective activity, appetite suppression, glycemic control and reduced side effects compared to THC, making it a potential treatment for management of obesity and diabetes. THCV was studied by Roger Adams as early as 1942.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.

Pharming, a portmanteau of farming and pharmaceutical, refers to the use of genetic engineering to insert genes that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a genetically modified organism (GMO). Pharming is also known as molecular farming, molecular pharming, or biopharming.

<span class="mw-page-title-main">Nabiximols</span> Specific cannabis extract

Nabiximols is a specific Cannabis extract that was approved in 2010 as a botanical drug in the United Kingdom. Nabiximols is sold as a mouth spray intended to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms of multiple sclerosis; it was developed by the UK company GW Pharmaceuticals. In 2019, it was proposed that following application of the spray, nabiximols is washed away from the oral mucosa by the saliva flow and ingested into the stomach, with subsequent absorption from the gastro-intestinal tract. Nabiximols is a combination drug standardized in composition, formulation, and dose. Its principal active components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). Each spray delivers a dose of 2.7 mg THC and 2.5 mg CBD.

<span class="mw-page-title-main">Cannabis Cup</span> Annual Festival in Amsterdam

The High TimesCannabis Cup is a cannabis festival sponsored by High Times magazine. The event features judges from around the world who sample and vote for their favorite marijuana varieties, with cups (trophies) being awarded to the overall winner in the cannabis variety competition. Since 1997, the Cannabis Cup festival has hosted induction ceremonies for the Counterculture Hall of Fame.

<span class="mw-page-title-main">THC-O-acetate</span> Acetate ester of tetrahydrocannabinol (THC)

THC-O-acetate is the acetate ester of THC. The term THC-O-acetate and its variations are commonly used for two types of the substance, dependent on which cannabinoid it is synthesized from. The difference between Δ8-THC and Δ9-THC is bond placement on the cyclohexene ring.

<i>Cannabis</i> strain Pure or hybrid varieties of cannabis

Cannabis strains are either pure or hybrid varieties of the plant genus Cannabis, which encompasses the species C. sativa, C. indica, and C. ruderalis.

<span class="mw-page-title-main">Poppy straw</span> Portion of opium poppy

Poppy straw is derived from opium poppies that are harvested when fully mature and dried by mechanical means. Opium poppy straw is what remains after the seed pods have been harvested - that is, the dried stalks, stem and leaves of poppies grown for their seeds. The field-dried leaves, stalk, and seed pod are then used in commercial manufacture of morphine or other poppy-alkaloid derived drugs, by first processing the material, separating the seeds, and then making concentrate of poppy straw where no extraction using the traditional methods of latex extraction has been made. The straw was originally considered an agricultural by-product of the mechanised poppy seed harvest, which was primarily grown for its edible and oil-producing seed. This changed in 1927 when János Kabay developed a chemical process to extract morphine from the crushed capsule. Concentrated poppy straw, consisting mainly of the crushed capsule without the seeds, soon became a valuable source of morphine. Today, concentrate of poppy straw is a major source of many opiates and other alkaloids. It is the source of 90% of the world supply of legal morphine and in some countries it also is a source of illegal morphine, which could be processed into illegal heroin.

<span class="mw-page-title-main">Hash oil</span> Oleoresin obtained by the extraction of cannabis or hashish

Hash oil or cannabis oil is an oleoresin obtained by the extraction of cannabis or hashish. It is a cannabis concentrate containing many of its resins and terpenes – in particular, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Hash oil is usually consumed by smoking, vaporizing or eating. Preparations of hash oil may be solid or semi-liquid colloids depending on both production method and temperature and are usually identified by their appearance or characteristics. Color most commonly ranges from transparent golden or light brown, to tan or black. There are various extraction methods, most involving a solvent, such as butane or ethanol.

<span class="mw-page-title-main">Dronabinol</span> Generic name of Δ9-THC in medicine

Dronabinol (INN), also known under the trade names Marinol and Syndros, is a generic name for the molecule of delta-9-tetrahydrocannabinol in the pharmaceutical context. It has indications as an appetite stimulant, antiemetic, and sleep apnea reliever and is approved by the FDA as safe and effective for HIV/AIDS-induced anorexia and chemotherapy-induced nausea and vomiting only.

<span class="mw-page-title-main">Arjan Roskam</span> Dutch breeder

Arjan Roskam is a cannabis entrepreneur, the founder of Green House coffeeshops and co-founder of Green House Seed Company. Roskam is known being part of the team that bred the Super Lemon Haze cannabis strain by crossing Lemon Skunk with Super Silver Haze. Roskam is also known as the (self-appointed) "King of Cannabis".

<span class="mw-page-title-main">GW Pharmaceuticals</span>

GW Pharmaceuticals Limited is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals.

<span class="mw-page-title-main">Robert Connell Clarke</span> Ethnobotanist

Robert Connell Clarke is an American agronomist and ethnobotanist, specialized in the study of the cannabis plant.

Nevil Martin Schoenmakers was an Australian-born cannabis breeder known for founding the first cannabis seedbank, which was called "The Seed Bank of Holland", in the early 1980s in the Netherlands. This was also the first seed company to advertise directly to the public in High Times magazine.

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.

The entourage effect is a marketing slogan that purports cannabis compounds other than tetrahydrocannabinol (THC) act synergistically with it to modulate the overall psychoactive effects of the plant.

<span class="mw-page-title-main">Government Pharmaceutical Organization</span> State enterprise of Thailand

The Government Pharmaceutical Organization (GPO) is a Thai state enterprise which manufactures pharmaceutical products in Thailand. In 2011, the GPO netted a profit of 1.6 billion baht from the sale of pharmaceuticals and medical equipment. As of 2011, the GPO employed 2,812 persons. In 2016, the organization produced drugs at two government-owned factories.

<span class="mw-page-title-main">Outline of cannabis</span> Overview of and topical guide to cannabis

The following outline is provided as an overview of and topical guide to the plant Cannabis sativa and its relatives Cannabis indica and Cannabis ruderalis, the drug cannabis (drug) and the industrial product hemp.

<span class="mw-page-title-main">VIVO Cannabis</span> Canadian licensed cannabis producer

VIVO Cannabis Inc(formerly ABcann Global) is a Canadian licensed cannabis producer, headquartered in Napanee, Ontario. Prior to being acquired by MediPharm Labs Corp., VIVO traded on the Toronto Stock Exchange as VIVO.

References

  1. "Hortapharm B.V." Archived from the original on 2013-10-05. Retrieved 2012-07-19.
  2. Breen, Bill (2004-02-01). "Dr. Dope's Connection". Fast Company. Retrieved 2019-08-07.
  3. "Details released of collaboration between GW Pharmaceuticals and Hortapharm medicinal cannabis". Archived from the original on 2012-07-30. Retrieved 2012-07-19.
  4. The Inheritance of Chemical Phenotype in Cannabis sativa L. (HortaPharm B.V., 1075 VS, Amsterdam, the Netherlands)
  5. "HortaPharm Interview". UK Journal. 1998.
  6. "Development of Cannabis-based therapeutics". International Hemp Association.
  7. "US patent for enhanced isolation chambers for ascending-stream extractive vaporizer". Justia Patents.